Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Yahoo Readies Itself for Sale

Yahoo, Inc. (YHOO) will begin releasing its financial information to potential buyers. Advisors Goldman Sachs group Inc. and Allen & Co. are preparing the information now. Reuters called it “a sign the troubled Internet giant is ready to put itself on the block.”

Yahoo icon

Yahoo Hinted This Was Coming

The information should come as no surprise. Yahoo executives sent a memo to employees last month saying they were “fielding inquiries from multiple parties that have already expressed interest in the number of potential options.”

Jack Ma May Be The Only One Who Wants All of Yahoo

There are several companies that have expressed interest in purchasing Yahoo. These include Jack Ma, the CEO of Chinese e-commerce giant Alibaba, and Silver Lake Partners. Ma especially made his interest known, when he told a group at Stanford University that he would be “very interested” in purchasing Yahoo in its entirety. Other potential buyers include several large technology and media companies, private equity groups, and international companies. But each has presented options regarding the sale of Yahoo’s various businesses. To date, Ma is the only one to express interest in buying all of Yahoo.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!